Miri, S. Et Al. 2024. Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study. Research and Practice in Thrombosis and Haemostasis , vol.8, no.8 .

Miri, S., Rosendaal, F. R., Kavakli, K., Eshghi, P., Moghaddam, S. M., Scardo, S., ... Habibpanah, B.(2024). Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study. Research and Practice in Thrombosis and Haemostasis , vol.8, no.8.

Miri, Syna Et Al. "Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study," Research and Practice in Thrombosis and Haemostasis , vol.8, no.8, 2024

Miri, Syna Et Al. "Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study." Research and Practice in Thrombosis and Haemostasis , vol.8, no.8, 2024

Miri, S. Et Al. (2024) . "Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study." Research and Practice in Thrombosis and Haemostasis , vol.8, no.8.

@article{article, author={Syna Miri Et Al. }, title={Inhibitor development upon switching from plasma-derived to recombinant factor VIII in previously untreated patients with severe hemophilia A: the PUP-SWITCH study}, journal={Research and Practice in Thrombosis and Haemostasis}, year=2024}